Pain Management Devices Market Size, Share, Trends and Industry Analysis By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Regional Forecast, 2019 - 2032

Table of Content:

1.      Introduction

1.1.   Research Scope

1.2.   Market Segmentation

1.3.   Research Methodology

1.4.   Definitions and Assumptions

2.      Executive Summary

3.      Market Dynamics

3.1.   Market Drivers

3.2.   Market Restraints

3.3.   Market Opportunities

4.      Key Insights

4.1.   Recent Industry Developments- Partnerships,Mergers, and Acquisitions

4.2.   Technological Advancements in Pain ManagementDevices Market

4.3.   Epidemics of Chronic Pain for Key Countries

4.4.   New Product Launch by Key Players

4.5.   Key Industry Trends

5.      Global Pain Management Devices MarketAnalysis, Insights and Forecast, 2015-2026

5.1.   Key Findings / Summary

5.2.   Market Analysis, Insights and Forecast – ByProduct Type

5.2.1.   Electrical Stimulation Devices

5.2.1.1.   TENS (Transcutaneous Electric NerveStimulation)

5.2.1.2.   EMS (Electric Muscle Stimulation)

5.2.1.3.   Others

5.2.2.   RF Ablation Devices

5.2.3.   Neuromodulation Devices

5.2.3.1.   Spinal Cord Stimulation

5.2.3.2.   Deep Brain Stimulation

5.2.3.3.   Others

5.2.4.   Infusion Pumps

5.3.   Market Analysis, Insights and Forecast – ByApplication

5.3.1.   Musculoskeletal

5.3.2.   Brain

5.3.3.   Cancer

5.3.4.   Neuropathic Pain

5.3.5.   Others

5.4.   Market Analysis, Insights and Forecast – ByEnd User

5.4.1.   Physiotherapy Centers

5.4.2.   Hospitals and Clinics

5.4.3.   Others (Home Care Settings and AmbulatorySurgery Centers)

5.5.   Market Analysis, Insights and Forecast – By Region/Country

5.5.1.   North America

5.5.2.   Europe

5.5.3.   Asia pacific

5.5.4.   Rest of the World

6.      North America Pain Management Devices MarketAnalysis, Insights and Forecast, 2015-2026

6.1.   Key Findings / Summary

6.2.   Market Analysis – By Product Type

6.2.1.   Electrical Stimulation Devices

6.2.1.1.   TENS (Transcutaneous Electric NerveStimulation)

6.2.1.2.   EMS (Electric Muscle Stimulation)

6.2.1.3.   Others

6.2.2.   RF Ablation Devices

6.2.3.   Neuromodulation Devices

6.2.3.1.   Spinal Cord Stimulation

6.2.3.2.   Deep Brain Stimulation

6.2.3.3.   Others

6.2.4.   Infusion Pumps

6.3.   Market Analysis – By Application

6.3.1.   Musculoskeletal

6.3.2.   Brain

6.3.3.   Cancer

6.3.4.   Neuropathic Pain

6.3.5.   Others

6.4.   Market Analysis – By End User

6.4.1.   Physiotherapy Centers

6.4.2.   Hospitals and Clinics

6.4.3.   Others (Home Care Settings and AmbulatorySurgery Centers)

6.5.   Market Analysis – By Country

6.5.1.   U.S.

6.5.2.   Canada

7.      Europe Pain Management Devices MarketAnalysis, Insights and Forecast, 2015-2026

7.1.   Key Findings / Summary

7.2.   Market Analysis – By Product Type

7.2.1.   Electrical Stimulation Devices

7.2.1.1.   TENS (Transcutaneous Electric Nerve Stimulation)

7.2.1.2.   EMS (Electric Muscle Stimulation)

7.2.1.3.   Others

7.2.2.   RF Ablation Devices

7.2.3.   Neuromodulation Devices

7.2.3.1.   Spinal Cord Stimulation

7.2.3.2.   Deep Brain Stimulation

7.2.3.3.   Others

7.2.4.   Infusion Pumps

7.3.   Market Analysis – By Application

7.3.1.   Musculoskeletal

7.3.2.   Brain

7.3.3.   Cancer

7.3.4.   Neuropathic Pain

7.3.5.   Others

7.4.   Market Analysis – By End User

7.4.1.   Physiotherapy Centers

7.4.2.   Hospitals and Clinics

7.4.3.   Others (Home Care Settings and AmbulatorySurgery Centers)

7.5.   Market Analysis – By Country

7.5.1.   U.K.

7.5.2.   Germany

7.5.3.   France

7.5.4.   Spain

7.5.5.   Italy

7.5.6.   Scandinavia

7.5.7.   Rest of Europe

8.      Asia pacific Pain Management Devices MarketAnalysis, Insights and Forecast, 2015-2026

8.1.   Key Findings / Summary

8.2.   Market Analysis – By Product Type

8.2.1.   Electrical Stimulation Devices

8.2.1.1.   TENS (Transcutaneous Electric NerveStimulation)

8.2.1.2.   EMS (Electric Muscle Stimulation)

8.2.1.3.   Others

8.2.2.   RF Ablation Devices

8.2.3.   Neuromodulation Devices

8.2.3.1.   Spinal Cord Stimulation

8.2.3.2.   Deep Brain Stimulation

8.2.3.3.   Others

8.2.4.   Infusion Pumps

8.3.   Market Analysis – By Application

8.3.1.   Musculoskeletal

8.3.2.   Brain

8.3.3.   Cancer

8.3.4.   Neuropathic Pain

8.3.5.   Others

8.4.   Market Analysis – By End User

8.4.1.   Physiotherapy Centers

8.4.2.   Hospitals and Clinics

8.4.3.   Others (Home Care Settings and AmbulatorySurgery Centers)

8.5.   Market Analysis – By Country

8.5.1.   Japan

8.5.2.   China

8.5.3.   India

8.5.4.   Australia

8.5.5.   Southeast Asia

8.5.6.   Rest of Asia Pacific

9.      Rest of the World Pain Management DevicesMarket Analysis, Insights and Forecast, 2015-2026

9.1.   Key Findings / Summary

9.2.   Market Analysis – By Product Type

9.2.1.   Electrical Stimulation Devices

9.2.1.1.   TENS (Transcutaneous Electric NerveStimulation)

9.2.1.2.   EMS (Electric Muscle Stimulation)

9.2.1.3.   Others

9.2.2.   RF Ablation Devices

9.2.3.   Neuromodulation Devices

9.2.3.1.   Spinal Cord Stimulation

9.2.3.2.   Deep Brain Stimulation

9.2.3.3.   Others

9.2.4.   Infusion Pumps

9.3.   Market Analysis – By Application

9.3.1.   Musculoskeletal

9.3.2.   Brain

9.3.3.   Cancer

9.3.4.   Neuropathic Pain

9.3.5.   Others

9.4.   Market Analysis – By End User

9.4.1.   Physiotherapy Centers

9.4.2.   Hospitals and Clinics

9.4.3.   Others (Home Care Settings and AmbulatorySurgery Centers)

10.  Competitive Analysis

10.1.  Key Industry Developments

10.2.  Global Market Share Analysis (2018)

10.3.  Competition Dashboard

10.4.  Comparative Analysis – Major Players

10.5.  Company Profiles (Overview, Products &Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based onAvailability))

10.5.1.  Medtronic

10.5.2.  Boston Scientific Corporation

10.5.3.  LivaNova

10.5.4.  Abbott

10.5.5.  DJO Global LLC

10.5.6.  SPR Therapeutics

10.5.7.  Nevro Corp

10.5.8.  Baxter

10.5.9.  Biomedical Inc.

11.  StrategicRecommendations